Search
Contact
04.12.2024 | Deal Notifications

KPMG Law and KPMG advises Brain Biotech AG on license agreements and monetization of license rights

KPMG Law Rechtsanwaltsgesellschaft mbH and KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG) advised Brain Biotech AG on the monetization of licensing rights with Royalty Pharma and the conclusion of an exclusive pharmaceutical licensing agreement for the G-dase-E®-CRISPR-Cas technology with Akribion Therapeutics.

BRAIN Biotech has entered into an agreement with Royalty Pharma for the monetization of the license rights to the investigational pharmaceutical compound deucrictibant in the amount of up to EUR 128.88 million. BRAIN Biotech will receive an upfront payment of EUR 18.41 million, additional potential regulatory milestone payments of up to EUR 18.42 million and additional potential long-term sales-related milestones of up to EUR 92.05 million. In addition, BRAIN Biotech has entered into an exclusive technology license agreement with Akribion Therapeutics GmbH for the use of the genome editing nuclease G-dase E® for the pharmaceutical sector. BRAIN Biotech will receive up to EUR 92.3 million in R&D and commercial milestone payments from Akribion for the granting of these exclusive rights for use in the pharmaceutical field. In addition, BRAIN Biotech will be entitled to royalties from future net sales. The payment structure is based on progress in clinical development and future commercialization success. KPMG Law provided comprehensive legal advice on the structuring of the transaction, including all aspects of copyright, licensing and transaction law. The accounting and tax advice as well as the comprehensive valuation of the licenses was provided by a KPMG team. Royalty Pharma was advised by an international team from Goodwin Procter. Advisor Brain Biotech AG:

KPMG Law Rechtsanwaltsgesellschaft mbH: Stefan Kimmel (Partner, Corporate/M&A, Berlin), Dr. Anna Wipper (Partner, IP/IT, Berlin) – both lead – Gunars Urdze (Senior Manager, Corporate, M&A, Cologne), Dr. Thomas Beyer (Senior Manager, IP/IT, Berlin), Isabelle Knoché (Senior Manager, Legal Financial Services, Frankfurt/Main), Christina Laux (Senior Associate , Legal Financial Services, Frankfurt/Main),; Dr. Jonas Brueckner (Partner, Antitrust and Foreign Trade Law, Berlin).

KPMG AG Wirtschaftsprüfungsgesellschaft: Christian Klingbeil (Partner, Valuation, Head of Deal Advisory Life Science, Munich), Sebastian Bongartz (Senior Manager, International Transaction Tax, Düsseldorf).

 

Explore #more

03.04.2025 | KPMG Law Insights

First Omnibus Package to relax the obligations of the CSDDD, CSRD and EU taxonomy

The EU Commission has today published the draft of the first announced Omnibus Package. With the first directive as part of the omnibus initiative,…

24.03.2025 | KPMG Law Insights

Product piracy in online retail: these are the latest tricks

Product piracy is also flourishing with the growth in online trade. A major problem for brand owners, but also a challenge for online marketplaces and…

24.03.2025 | Deal Notifications

KPMG Law advises Munich Airport on the sale of aerogate München Gesellschaft für Luftverkehrsabfertigungen mbH

KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) provided legal advice to Flughafen München GmbH (FMG) on the sale of its subsidiary aerogate München Gesellschaft für Luftverkehrsabfertigungen…

21.03.2025 | KPMG Law Insights

Special infrastructure assets: how the administration manages to implement projects quickly

The special infrastructure fund creates the opportunity to catch up on years of investment backlog. There is a need for urgency. Defence capability, economic growth…

20.03.2025 | KPMG Law Insights

AI Act: This applies to AI in universities and research

Artificial intelligence (AI) offers numerous opportunities for research, teaching and administration, but also raises complex legal issues. The European Union’s AI Regulation(AI Act)…

19.03.2025 | In the media

BUJ/KPMG Law Summit Transformation

The Bundesverband der Unternehmensjuristinnen und Unternehmensjuristen e.V. (BUJ) and KPMG Law cordially invite you to the BUJ Summit Transformation on May 28, 2025 in Frankfurt…

18.03.2025 | In the media

KPMG Law Statement in the German transport magazine DVZ: Planning at a crawl; DIHK sees great potential for faster traffic route construction

The Chamber of Commerce in Arnsberg regularly awards prizes to the worst state roads in the Hellweg-Sauerland region of Westphalia. A funny idea, if it…

13.03.2025 | KPMG Law Insights

ECJ tightens antitrust liability for information exchange

The ECJ (C-298/22) has recently set strict standards for the permissible exchange of information between companies. As a result, companies are now even more faced…

11.03.2025 | In the media

KPMG Law Interview with HAUFE: LkSG after the elections – everything new?

Many companies have made considerable efforts to implement the Supply Chain Due Diligence Act. The political discussion about its abolition is now causing uncertainty. KPMG…

07.03.2025 | In the media

Guest article in unternehmensjurist: Implementing the requirements of the BFSG correctly

The Barrier-Free Accessibility Reinforcement Act requires companies to offer certain products and services without barriers. The obligations vary depending on the role in business transactions.…

© 2024 KPMG Law Rechtsanwaltsgesellschaft mbH, associated with KPMG AG Wirtschaftsprüfungsgesellschaft, a public limited company under German law and a member of the global KPMG organisation of independent member firms affiliated with KPMG International Limited, a Private English Company Limited by Guarantee. All rights reserved. For more details on the structure of KPMG’s global organisation, please visit https://home.kpmg/governance.

 KPMG International does not provide services to clients. No member firm is authorised to bind or contract KPMG International or any other member firm to any third party, just as KPMG International is not authorised to bind or contract any other member firm.

Scroll